Intravenous Methylprednisolone
RJ115/N065
Phase 3 small_molecule terminated
Quick answer
Intravenous Methylprednisolone for Myelitis, Transverse is a Phase 3 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cardiff Oncology
- Indication
- Myelitis, Transverse
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated